Engineered Nanostructures of Antigen Provide an Effective Means for Regulating Mast Cell Activation

ACS Nano - United States
doi 10.1021/nn202510n
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Chemical Society (ACS)

Related search

Pharmacological Treatment Options for Mast Cell Activation Disease

Naunyn-Schmiedeberg's Archives of Pharmacology
MedicinePharmacology
2016English

Contribution of Engineered Nanomaterials Physicochemical Properties to Mast Cell Degranulation

Scientific Reports
Multidisciplinary
2017English

Mast Cell Activation and Mediator Release

Chemical Immunology and Allergy
1984English

Deciphering New Molecular Mechanisms of Mast Cell Activation

Frontiers in Immunology
AllergyImmunology
2013English

Utility of Hydroxyurea in Mast Cell Activation Syndrome

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2013English

An Usual Presentation of Mast Cell Activation Syndrome and Pancreatic Neuroendocrine Tumor (PanNET)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Engineered Nanostructures for Optimal Strength and Toughness

2009English

Recent Advances in Mast Cell Activation and Regulation

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2020English

Antigen-Presenting Dendritic Cells Provide the Reducing Extracellular Microenvironment Required for T Lymphocyte Activation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy